8th Asia Pacific Glaucoma Congress
24-26 July 2026

  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

AbbVie Philippines Inc

As a new biopharmaceutical company, AbbVie combines the expertise of a recognised pharmaceutical company with the focus and innovative spirit of a biotech. Through a targeted, patient-centric approach to research and development, AbbVie accelerates new scientific discoveries to address some of the most complex diseases in the world, while our services and partnerships help us create greater access and outcomes for the health of all Australians.

We focus on discovering, developing, and delivering medicines in therapeutic areas where we have proven expertise and where we can have an impact. These areas include: Immunology, Oncology, Virology and Neuroscience.

Exhibitors, Gold Partner

Abstract submission deadline extended

Important dates
Submission open: NOW!
Submission close: 1 Dec 2023 Monday 15 January 2024
Author notifications: 15 February 2024